China SXT Pharmaceuticals (SXTC) Goodwill & Intangibles (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Goodwill & Intangibles for 9 consecutive years, with $6328.0 the latest figure, recorded in Q1 2026.

• Quarterly Goodwill & Intangibles fell 46.41% year-over-year to $6328.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6328.0 (down 46.41% YoY) and the FY2026 annual result came in at $6328.0, down 46.41% from the prior year.
• Goodwill & Intangibles eased to $6328.0 in Q1 2026 per SXTC's latest filing, from $8532.0 in the prior quarter.
• Over the last five years, Goodwill & Intangibles for SXTC reached as high as $85728.0 in Q1 2022 and fell as low as $6328.0 in Q1 2026.
• A 5-year average of $25389.0 and a median of $19101.0 in 2024 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles grew 3.35% — and 2023, when it tumbled 67.49%.
• Year by year, Goodwill & Intangibles stood at $30724.0 in 2022, then slipped by 26.72% to $22514.0 in 2023, then slipped by 29.39% to $15898.0 in 2024, then tumbled by 46.33% to $8532.0 in 2025, then fell by 25.83% to $6328.0 in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $6328.0, $8532.0, and $11808.0 for Q1 2026, Q3 2025, and Q1 2025 respectively.